These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38101956)

  • 1. Beyond probiotics: postbiotics sensitize cancer cells to immune checkpoint inhibitors.
    Liu W; Pi Z; Mao W
    Trends Cancer; 2024 Jan; 10(1):5-7. PubMed ID: 38101956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to immune checkpoint inhibitors.
    Nagasaki J; Ishino T; Togashi Y
    Cancer Sci; 2022 Oct; 113(10):3303-3312. PubMed ID: 35848888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I.
    Ferrari V; Lo Cascio A; Melacarne A; Tanasković N; Mozzarelli AM; Tiraboschi L; Lizier M; Salvi M; Braga D; Algieri F; Penna G; Rescigno M
    Cancer Cell; 2023 Oct; 41(10):1717-1730.e4. PubMed ID: 37738976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines.
    Oladejo M; Paulishak W; Wood L
    Semin Cancer Biol; 2023 Jan; 88():81-95. PubMed ID: 36526110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A Review.
    Cruellas M; Yubero A; Zapata M; Galvez EM; Gascón M; Isla D; Lastra R; Martínez-Lostao L; Ocariz M; Pardo J; Ramírez A; Sesma A; Torres-Ramón I; Paño JR
    Infect Immun; 2021 Aug; 89(9):e0066520. PubMed ID: 33526567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review).
    Wang Y; Yang S; Wan L; Ling W; Chen H; Wang J
    Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37326100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs).
    Rallis KS; Hillyar CRT; Sideris M; Davies JK
    Anticancer Res; 2021 Mar; 41(3):1123-1141. PubMed ID: 33788704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to immune checkpoint inhibitors and the tumor microenvironment.
    Kawashima S; Togashi Y
    Exp Dermatol; 2023 Mar; 32(3):240-249. PubMed ID: 36437644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Checkpoint Inhibitors: Recent Clinical Advances and Future Prospects.
    Banday AH; Abdalla M
    Curr Med Chem; 2023; 30(28):3215-3237. PubMed ID: 35986535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to Immune Checkpoint Blockade: IFNγ or MHC-I?
    Haugh A; Daud A
    Cancer Immunol Res; 2023 Jul; 11(7):864. PubMed ID: 37262325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies.
    Pérez-Ruiz E; Melero I; Kopecka J; Sarmento-Ribeiro AB; García-Aranda M; De Las Rivas J
    Drug Resist Updat; 2020 Dec; 53():100718. PubMed ID: 32736034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care.
    Singh S; Numan A; Agrawal N; Tambuwala MM; Singh V; Kesharwani P
    Int Immunopharmacol; 2020 Jun; 83():106417. PubMed ID: 32200155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy.
    Zemek RM; Chin WL; Nowak AK; Millward MJ; Lake RA; Lesterhuis WJ
    Front Immunol; 2020; 11():223. PubMed ID: 32133005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB and Its Role in Checkpoint Control.
    Betzler AC; Theodoraki MN; Schuler PJ; Döscher J; Laban S; Hoffmann TK; Brunner C
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
    Roberto M; Carconi C; Cerreti M; Schipilliti FM; Botticelli A; Mazzuca F; Marchetti P
    Front Immunol; 2021; 12():704942. PubMed ID: 34489956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?
    Lentz RW; Colton MD; Mitra SS; Messersmith WA
    Mol Cancer Ther; 2021 Jun; 20(6):961-974. PubMed ID: 33850005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy.
    Gavali S; Liu J; Li X; Paolino M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway.
    Zheng X; Luo Y; Xiong Y; Liu X; Zeng C; Lu X; Wang X; Cheng Y; Wang S; Lan H; Wang K; Weng Z; Bi W; Gan X; Jia X; Wang L; Wang Y
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.